Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
about
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancerHepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis.Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
P2860
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Phase II randomised trial of r ...... in advanced colorectal cancer.
@ast
Phase II randomised trial of r ...... in advanced colorectal cancer.
@en
type
label
Phase II randomised trial of r ...... in advanced colorectal cancer.
@ast
Phase II randomised trial of r ...... in advanced colorectal cancer.
@en
prefLabel
Phase II randomised trial of r ...... in advanced colorectal cancer.
@ast
Phase II randomised trial of r ...... in advanced colorectal cancer.
@en
P2093
P2860
P356
P1476
Phase II randomised trial of r ...... in advanced colorectal cancer
@en
P2093
A Pelegrín
C Castañón
E González
L López-Gómez
M González-Barón
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602860
P407
P577
2005-11-01T00:00:00Z